MAGNETOLITH® EMTT®
Extracorporeal Magnetotransduction Therapy
Extracorporeal Magnetotransduction Therapy (EMTT®)
The Storz MAGNETOLITH® brings EMTT® technology to your clinic, opening new revenue streams and treatment possibilities for musculoskeletal conditions your patients are actively seeking solutions for.
EMTT® operates at a high oscillation frequency of 100 to 300 kHz, giving it 40% greater field strength than PEMF and a tissue penetration depth of 18 cm. This means you can treat a far wider range of MSK indications at a cellular and nerve level, including chronic tendinopathies, joint conditions, lower back pain and soft tissue injuries, with no consumables, no technician required and no hands-on treatment time.
For clinics looking to expand their regenerative therapy offering, EMTT® delivers measurable clinical outcomes backed by peer-reviewed research.
The Biological Effects of EMTT® Treatment
All cells rely on chemical reactions that support their metabolism, and a key requirement for these reactions is the permeability of the cell membrane. When cell membrane function is disrupted, whether through injury, inflammation or degenerative conditions, normal cellular processes break down.
EMTT® works by generating a therapeutically effective magnetic field that penetrates deep into tissue, reactivating the sodium-potassium pump and restoring normal cellular activity. The result is a measurable reduction in inflammation, improved tissue repair and pain relief at the source.
- Therapeutically effective magnetic field
- Restoration of membrane potential
- Mechanical stimulation of ion channels
The Effect of Electromagnetic Stimulation on Our Cells
Electromagnetic stimulation, as used in EMTT®, can relieve pain and reduce inflammation by triggering the oscillating magnetic field generated in the coil, which stimulates cells and increases membrane permeability.
This stimulation allows certain ions and molecules to pass more easily into the cell, where they initiate chain reactions that inhibit inflammatory processes and accelerate the breakdown of inflammatory substances, resulting in a measurable reduction in inflammation and pain in the treated area.
Magnetolith Ultra + EMTT® Indications
Magnetolith EMTT® is the only approved electromagnetic therapy for the treatment of musculoskeletal diseases of the muscle, bone, joints, nerves, tendons and tissues. Health care professionals are using electromagnetic transduction therapy for:
- Degenerative Joint Diseases - Arthrosis of the knee, hip, hands, shoulder and elbow, herniated disc, spondylarthrosis
- Chronic Pain - Lower back pain, lumbalgia, radiculopathies, tension-related pain and heel pain
- Sports Injuries - Chronic tendon and joint inflammation, tendon overload syndrome, osteitis pubis
- Bone Healing - Stress fractures, non-union fractures, osseocrosis and implant osseointegration
- Nerve Entrapments - Carpal tunnel syndrome, sciatica and peripheral nerve compression
How does Magnetolith EMTT® differ from Pulsed Electromagnetic Fields (PEMF)?
EMTT® operates at a high oscillation frequency of 100 – 300 kHz, which sets it apart from general forms of electromagnetic field therapy and PEMF. This higher frequency gives EMTT® 40% greater field strength and a tissue penetration depth of 18 cm, working at a cellular and nerve level rather than addressing only superficial muscle tissue.
The result is a significantly broader range of treatable MSK indications when compared to PEMF, with faster and more measurable clinical outcomes.
EMTT® is very well tolerated by patients. Any mild skin sensitivity experienced during treatment is brief and minor when weighed against the clinically relevant reduction in pain and inflammation the therapy delivers.
Clinical Advantages of EMTT® Therapy
A Comfortable and Straightforward treatment
EMTT® is non-invasive and well tolerated by patients, with sessions typically running between 5 and 20 minutes. Clinicians will also appreciate the ease of use, with no complex setup or specialist training required.
EMTT® is a ‘hands free’ treatment
Thanks to excellent engineering of the articulated arm, EMTT® is a ‘touch-free’ treatment, perfectly suited for unattended therapy and minimal patient contact.
Low Running Costs, Strong ROI
Magnetolith EMTT® does not require any special maintenance or technician to use and is low cost to run, providing your clinic maximum return on investment.
MASTERPULS® R-SW100 Specifications
- Intensity range: 9 levels (30 - 90 mT; 10mT steps)
- Frequency range: 1 - 10 Hz (80mT @8Hz)
- Storz Magnetolith Trolly
- Built-in touchscreen display
- Storz Magnetolith articulating applicator arm for handsfree treatment
- Comprehensive in-person training
- Dimensions (W x H x D): 16.77 × 5.67 × 13.39 inches
- Travel bag available
EMTT® Clinical Publications
Extracorporeal Magnetotransduction Therapy is backed by a growing body of peer-reviewed research across a wide range of musculoskeletal conditions.
EMTT® Frequently Asked Questions
Everything you need to know about Extracorporeal Magnetotransduction Therapy before bringing the MAGNETOLITH® into your clinic.
EMTT is a non-invasive therapeutic procedure developed specifically for the treatment of chronic and acute musculoskeletal disorders. It targets the muscles, bones, joints, tendons and ligaments using high-frequency magnetic fields, without the need for skin contact, injections or recovery time.
Since its introduction, EMTT has been well tolerated across a broad range of patient populations and is supported by a growing body of peer-reviewed clinical research.
EMTT is indicated across a wide range of musculoskeletal conditions, including:
- Degenerative joint conditions such as arthrosis of the knee, hip, shoulder and elbow
- Chronic pain including lower back pain, lumbalgia, radiculopathies and heel pain
- Sports injuries including tendinopathy, tendon overload syndrome and osteitis pubis
- Bone healing including stress fractures, non-union fractures and implant osseointegration
- Nerve entrapments such as carpal tunnel syndrome and sciatica
EMTT operates at a significantly higher oscillation frequency of 100 to 300 kHz compared to standard PEMF therapy. This results in a much stronger effective transduction output and a tissue penetration depth of up to 18 cm, allowing treatment of deep anatomical structures that PEMF cannot reach.
EMTT is 40% stronger than PEMF and works at a cellular and nerve level rather than addressing only superficial muscle tissue, expanding the range of treatable indications considerably.
Treatment is straightforward and comfortable for the patient. The MAGNETOLITH articulated arm is positioned over the target area such as the lower back, knee or shoulder, and high-energy magnetic pulses are delivered through clothing without any direct skin contact required.
Each session typically lasts between 5 and 20 minutes depending on the indication. A full course of treatment generally involves up to 8 sessions over several weeks, adjusted based on the severity of the condition and the patient's response.
EMTT has no reported serious side effects. Some patients may experience mild and brief skin sensitivity during treatment, which is minor when compared to the clinically relevant reduction in pain and inflammation the therapy delivers.
There is no temperature increase in the tissue during treatment due to the short duration of individual pulses, making it a safe option for a broad patient population.
No. The MAGNETOLITH is designed for straightforward clinical use and does not require a specialist technician to operate. Vale Medical provides comprehensive in-person or virtual training so your team can treat confidently from day one.
The device requires no consumables and minimal maintenance, keeping running costs low and maximising your return on investment.
Yes. EMTT is supported by a growing body of peer-reviewed research across a wide range of musculoskeletal indications including low back pain, rotator cuff tendinopathy, shoulder enthesopathies, bone healing and more. See the published studies and clinical trials in the research section above.